Stay updated on Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial

Sign up to get notified when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical trial record for the tipifarnib–alpelisib study is displayed, with details on its completed status, participant criteria, study sites, outcome measures, and study documents.
    Difference
    64%
    Check dated 2026-11-11T00:43:54.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:19:26.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the footer revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:45:15.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T22:45:41.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating an access restriction that prevents viewing the study details.
    Difference
    20%
    Check dated 2026-09-22T23:03:48.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    - The page now displays Revision: v3.7.0, replacing Revision: v3.6.6. This indicates a version update to the page; no user-facing study content appears to have changed.
    Difference
    0.0%
    Check dated 2026-09-15T21:36:27.000Z thumbnail image

Stay in the know with updates to Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.